Genetics

Research across three continents indicates that geography and ethnicity influence biological processes, aging, and disease risk.

An antibody-based approach for Fanconi anemia replaces traditional toxic conditioning with targeted therapy, allowing safe restoration of blood and immune function without chemotherapy or radiation.

New research suggests that certain genetic variants can decrease the ability of GLP-1 diabetes drugs to regulate blood sugar – a mysterious phenomenon known as GLP-1 resistance.

A “reverse translation” technique converts protein sequences into DNA, enabling unprecedented detection sensitivity.

Pediatrics Assistant Professor Agnieszka Czechowicz explains an innovative trial using maternal cells to treat Fanconi anemia in utero.

Sparse record-keeping during slavery has created gaps in African American family trees. New modeling offers valuable insights into genealogical connections.

Euan Ashley’s lab explores the intricate interactions of gene variants, reshaping our understanding of inherited heart diseases.

Stanford Medicine’s CRISPR-GPT leverages AI to assist scientists in the gene-editing process, with the potential to enhance the development of lifesaving treatments.

It took researchers a century to find the genetic glitch that causes orange coloration in cats.

A new Stanford Medicine study has identified single nucleotide variants that are essential to drive cancer growth. The findings could enhance genetic screening and aid in the development of new therapies.